NT

Naresh Taggar

Active Director Director DIN 07872578
DIN 07872578 First appointment Jul 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2017
Shareholding value •••• Premium profile

About Naresh Taggar

Data last updated:

Naresh Taggar is a Director at Siraigo Pharma Private Limited (since 2017). The company operates in Pharma. Siraigo Pharma Private Limited reported revenue of ₹2.00 Cr (FY 2024).

DIN 07872578
Primary Designation Director
Industry Pharma
First Appointment 05 Jul 2017
Oldest Company Age 22 yrs
Largest company Siraigo Pharma Private Limited · ₹2.00 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Siraigo Pharma Private Limited U24230MH2004PTC146558
Director05 Jul 20172004₹2.00 Cr (FY 2024)Active

Board colleagues of Naresh Taggar

NameDINCompanyDesignation
Balvinder Kaur07871713Siraigo Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Siraigo Pharma Private Limited
Premium access

Shareholding and investment profile for Naresh Taggar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Naresh Taggar

Naresh Taggar currently holds 1 directorship: Siraigo Pharma Private Limited (Director, since 05 Jul 2017, revenue ₹2.00 Cr (FY 2024)).

Naresh Taggar was first appointed on 05 Jul 2017 as Director at Siraigo Pharma Private Limited.

The current boards of Naresh Taggar's companies include Balvinder Kaur (Siraigo Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available